A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).

NCT02462759 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
21
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated early to roll over participants to open label extension study NCT02594124.

Conditions

Interventions

Sponsor

Biogen